Izzat T Raheem

9PUBLICATIONS

34CO-AUTHORS

Pharmaceutical delivery technologiesMedical molecular engineering of nucleic acids and proteinsMedical bacteriologyBiologically active moleculesInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Sep 11, 2026

Allosteric Crosstalk between Inhibitor Binding Sites Drives Enhanced Islatravir Susceptibility in F227C HIV-1 Reverse Transcriptase.

|Aug 26, 2025

MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosing.

Izzat T Raheem, Vinay Girijavallabhan, Kerry L Fillgrove

|Aug 22, 2024

Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat Acinetobacter baumannii: From Screening Impurity to In Vivo Efficacy.

Jason W Skudlarek, Andrew J Cooke, Helen J Mitchell

|Aug 14, 2024

Discovery of Broad-Spectrum Herpes Antiviral Oxazolidinone Amide Derivatives and Their Structure-Activity Relationships.

Michael A Plotkin, Marc Labroli, Jeffrey Schubert

|May 20, 2024

Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.

Chengwei Wu, Izzat T Raheem, Debbie D Nahas

|Apr 22, 2024

Cerastecins inhibit membrane lipooligosaccharide transport in drug-resistant Acinetobacter baumannii.

Hao Wang, Andrii Ishchenko, Jason Skudlarek

Pageof 2

Frequent Collaborators

Douglas C Beshore

Scott S Walker

Jason W Skudlarek

Andrew M Haidle

Yeon-Hee Lim

Anthony J Roecker

Samantha E Shockley

Mark E Layton

William D Shipe

Georgia B McGaughey

Frequent Collaborators

Douglas C Beshore

Scott S Walker

Jason W Skudlarek

Andrew M Haidle